journal
https://read.qxmd.com/read/38614991/early-life-house-dust-mite-aeroallergen-exposure-augments-cigarette-smoke-induced-myeloid-inflammation-and-emphysema-in-mice
#1
JOURNAL ARTICLE
Nok Him Fung, Quynh Anh Nguyen, Catherine Owczarek, Nick Wilson, Nadeem Elahee Doomun, David De Souza, Kylie Quinn, Stavros Selemidis, Jonathan McQualter, Ross Vlahos, Hao Wang, Steven Bozinovski
BACKGROUND: Longitudinal studies have identified childhood asthma as a risk factor for obstructive pulmonary disease (COPD) and asthma-COPD overlap (ACO) where persistent airflow limitation can develop more aggressively. However, a causal link between childhood asthma and COPD/ACO remains to be established. Our study aimed to model the natural history of childhood asthma and COPD and to investigate the cellular/molecular mechanisms that drive disease progression. METHODS: Allergic airways disease was established in three-week-old young C57BL/6 mice using house dust mite (HDM) extract...
April 13, 2024: Respiratory Research
https://read.qxmd.com/read/38600600/phenotypes-and-outcome-of-diffuse-pulmonary-non-amyloid-light-chain-deposition-disease
#2
JOURNAL ARTICLE
François Lestelle, Catherine Beigelman, David Rotzinger, Salim Si-Mohamed, Mouhamad Nasser, Lidwine Wemeau, Sandrine Hirschi, Grégoire Prevot, Antoine Roux, Vincent Bunel, Emmanuel Gomez, Laurent Sohier, Helene Morisse Pradier, Martine Reynaud Gaubert, Anne Gondouin, Romain Lazor, Jean-Charles Glerant, Françoise Thivolet Bejui, Magali Colombat, Vincent Cottin
BACKGROUND: Light chain deposition disease (LCDD) is a very rare entity. Clinical manifestations of LCDD vary according to the organs involved. Data on pulmonary LCDD are scarce and limited to small series or case reports. This study aimed to describe the characteristics and outcome of diffuse pulmonary non-amyloid LCDD localized to the lungs. STUDY DESIGN AND METHODS: A multicenter retrospective cohort study was conducted. Clinical characteristics were collected, and chest CTs were centrally reviewed...
April 10, 2024: Respiratory Research
https://read.qxmd.com/read/38600524/loss-of-znf451-mediates-fibroblast-activation-and-promotes-lung-fibrosis
#3
JOURNAL ARTICLE
Hong Peng, Yu Zhang, Jiali Min, Yuexin Tan, Shanshan Liu
BACKGROUND: No effective therapies for pulmonary fibrosis (PF) exist because of the unclear molecular pathogenesis and the lack of effective therapeutic targets. Zinc finger protein 451 (ZNF451), a transcriptional regulator, plays crucial roles in the pathogenesis of several diseases. However, its expression pattern and function in PF remain unknown. This study was designed to investigate the role of ZNF451 in the pathogenesis of lung fibrosis. METHODS: GEO dataset analysis, RT‒PCR, and immunoblot assays were used to examine the expression of ZNF451 in PF; ZNF451 knockout mice and ZNF451-overexpressing lentivirus were used to determine the importance of ZNF451 in PF progression; and migration assays, immunofluorescence staining, and RNA-seq analysis were used for mechanistic studies...
April 10, 2024: Respiratory Research
https://read.qxmd.com/read/38594707/glut3-mediated-cigarette-smoke-induced-epithelial-mesenchymal-transition-in-chronic-obstructive-pulmonary-disease-through-the-nf-kb-zeb1-pathway
#4
JOURNAL ARTICLE
Yu Ding, Ziteng Wang, Zheming Zhang, Rong You, Yan Wu, Tao Bian
BACKGROUND: Airway remodelling plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). Epithelial-mesenchymal transition (EMT) is a significant process during the occurrence of airway remodelling. Increasing evidence suggests that glucose transporter 3 (GLUT3) is involved in the epithelial mesenchymal transition (EMT) process of various diseases. However, the role of GLUT3 in EMT in the airway epithelial cells of COPD patients remains unclear. METHODS: We detected the levels of GLUT3 in the peripheral lung tissue of COPD patients and cigarette smoke (CS)-exposed mice...
April 9, 2024: Respiratory Research
https://read.qxmd.com/read/38594676/targeting-transitioning-lung-monocytes-macrophages-as-treatment-strategies-in-lung-disease-related-to-environmental-exposures
#5
JOURNAL ARTICLE
Aaron D Schwab, Todd A Wyatt, Grace Moravec, Geoffrey M Thiele, Amy J Nelson, Angela Gleason, Oliver Schanze, Michael J Duryee, Debra J Romberger, Ted R Mikuls, Jill A Poole
BACKGROUND: Environmental/occupational exposures cause significant lung diseases. Agricultural organic dust extracts (ODE) and bacterial component lipopolysaccharide (LPS) induce recruited, transitioning murine lung monocytes/macrophages, yet their cellular role remains unclear. METHODS: CCR2 RFP+ mice were intratracheally instilled with high concentration ODE (25%), LPS (10 μg), or gram-positive peptidoglycan (PGN, 100 μg) for monocyte/macrophage cell-trafficking studies...
April 9, 2024: Respiratory Research
https://read.qxmd.com/read/38581044/use-of-non-small-cell-lung-cancer-multicellular-tumor-spheroids-to-study-the-impact-of-chemotherapy
#6
JOURNAL ARTICLE
Pauline Hulo, Sophie Deshayes, Judith Fresquet, Anne-Laure Chéné, Stéphanie Blandin, Nicolas Boisgerault, Jean-François Fonteneau, Lucas Treps, Marc G Denis, Jaafar Bennouna, Delphine Fradin, Elvire Pons-Tostivint, Christophe Blanquart
BACKGROUND: Lung cancers represent the main cause of cancer related-death worldwide. Recently, immunotherapy alone or in combination with chemotherapy has deeply impacted the therapeutic care leading to an improved overall survival. However, relapse will finally occur, with no efficient second line treatment so far. New therapies development based on the comprehension of resistance mechanisms is necessary. However, the difficulties to obtain tumor samples before and after first line treatment hamper to clearly understand the consequence of these molecules on tumor cells and also to identify adapted second line therapies...
April 5, 2024: Respiratory Research
https://read.qxmd.com/read/38570835/updated-reference-values-for-static-lung-volumes-from-a-healthy-population-in-austria
#7
JOURNAL ARTICLE
Tobias Mraz, Shervin Asgari, Ahmad Karimi, Marie-Kathrin Breyer, Sylvia Hartl, Owat Sunanta, Alina Ofenheimer, Otto C Burghuber, Angela Zacharasiewicz, Bernd Lamprecht, Caspar Schiffers, Emiel F M Wouters, Robab Breyer-Kohansal
BACKGROUND: Reference values for lung volumes are necessary to identify and diagnose restrictive lung diseases and hyperinflation, but the values have to be validated in the relevant population. Our aim was to investigate the Global Lung Function Initiative (GLI) reference equations in a representative healthy Austrian population and create population-derived reference equations if poor fit was observed. METHODS: We analysed spirometry and body plethysmography data from 5371 respiratory healthy subjects (6-80 years) from the Austrian LEAD Study...
April 3, 2024: Respiratory Research
https://read.qxmd.com/read/38566174/a-wnt-mimetic-with-broad-spectrum-fzd-specificity-decreases-fibrosis-and-improves-function-in-a-pulmonary-damage-model
#8
JOURNAL ARTICLE
Mehaben Patel, Yorick Post, Natalie Hill, Asmiti Sura, Jay Ye, Trevor Fisher, Nicholas Suen, Mengrui Zhang, Leona Cheng, Ariel Pribluda, Hui Chen, Wen-Chen Yeh, Yang Li, Hélène Baribault, Russell B Fletcher
BACKGROUND: Wnt/β-catenin signaling is critical for lung development and AT2 stem cell maintenance in adults, but excessive pathway activation has been associated with pulmonary fibrosis, both in animal models and human diseases such as idiopathic pulmonary fibrosis (IPF). IPF is a detrimental interstitial lung disease, and although two approved drugs limit functional decline, transplantation is the only treatment that extends survival, highlighting the need for regenerative therapies...
April 2, 2024: Respiratory Research
https://read.qxmd.com/read/38566093/nr2f2-alleviates-pulmonary-fibrosis-by-inhibition-of-epithelial-cell-senescence
#9
JOURNAL ARTICLE
Ruyan Wan, Siqi Long, Shuaichen Ma, Peishuo Yan, Zhongzheng Li, Kai Xu, Hui Lian, Wenwen Li, Yudi Duan, Miaomiao Zhu, Lan Wang, Guoying Yu
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fatal, and aging-associated interstitial lung disease with a poor prognosis and limited treatment options, while the pathogenesis remains elusive. In this study, we found that the expression of nuclear receptor subfamily 2 group F member 2 (NR2F2), a member of the steroid thyroid hormone superfamily of nuclear receptors, was reduced in both IPF and bleomycin-induced fibrotic lungs, markedly in bleomycin-induced senescent epithelial cells. Inhibition of NR2F2 expression increased the expression of senescence markers such as p21 and p16 in lung epithelial cells, and activated fibroblasts through epithelial-mesenchymal crosstalk, inversely overexpression of NR2F2 alleviated bleomycin-induced epithelial cell senescence and inhibited fibroblast activation...
April 2, 2024: Respiratory Research
https://read.qxmd.com/read/38561798/the-safety-and-potential-efficacy-of-exosomes-overexpressing-cd24-exo-cd24-in-mild-moderate-covid-19-related-ards
#10
JOURNAL ARTICLE
Ioannis Grigoropoulos, Georgios Tsioulos, Artemis Kastrissianakis, Shiran Shapira, Orr Green, Vasiliki Rapti, Maria Tsakona, Thomas Konstantinos, Athina Savva, Dimitra Kavatha, Dimitrios Boumpas, Konstantinos Syrigos, Ioannis Xynogalas, Konstantinos Leontis, Vasileios Ntousopoulos, Vissaria Sakka, Zafeiris Sardelis, Andreas Fotiadis, Lamprini Vlassi, Chrysoula Kontogianni, Anastasia Levounets, Garyfalia Poulakou, Mina Gaga, Ronan MacLoughlin, Justin Stebbing, Nadir Arber, Anastasia Antoniadou, Sotirios Tsiodras
INTRODUCTION: EXO-CD24 are exosomes genetically manipulated to over-express Cluster of Differentiation (CD) 24. It consists of two breakthrough technologies: CD24, the drug, as a novel immunomodulator that is smarter than steroids without any side effects, and exosomes as the ideal natural drug carrier. METHODS: A randomized, single blind, dose-finding phase IIb trial in hospitalized patients with mild to moderate Coronavirus disease 2019 (COVID-19) related Acute Respiratory Distress Syndrome (ARDS) was carried out in two medical centers in Athens...
April 1, 2024: Respiratory Research
https://read.qxmd.com/read/38561735/correction-benefit-of-prompt-initiation-of-single-inhaler-fluticasone-furoate-umeclidinium-and-vilanterol-ff-umec-vi-in-patients-with-copd-in-england-following-an-exacerbation-a-retrospective-cohort-study
#11
Afisi S Ismaila, Kieran J Rothnie, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N Millard, Olivia Massey, David M G Halpin
No abstract text is available yet for this article.
April 1, 2024: Respiratory Research
https://read.qxmd.com/read/38555460/a-novel-quinoline-with-airway-relaxant-effects-and-anti-inflammatory-properties
#12
JOURNAL ARTICLE
Jesper Bergwik, Jielu Liu, Médea Padra, Ravi K V Bhongir, Lloyd Tanner, Yujiao Xiang, Mia Lundblad, Arne Egesten, Mikael Adner
BACKGROUND: In chronic pulmonary diseases characterized by inflammation and airway obstruction, such as asthma and COPD, there are unmet needs for improved treatment. Quinolines is a group of small heterocyclic compounds that have a broad range of pharmacological properties. Here, we investigated the airway relaxant and anti-inflammatory properties of a novel quinoline (RCD405). METHODS: The airway relaxant effect of RCD405 was examined in isolated airways from humans, dogs, rats and mice...
March 30, 2024: Respiratory Research
https://read.qxmd.com/read/38555459/longitudinal-bmi-change-and-outcomes-in-chronic-obstructive-pulmonary-disease-a-nationwide-population-based-cohort-study
#13
JOURNAL ARTICLE
Taeyun Kim, Sun Hye Shin, Hyunsoo Kim, Yunjoo Im, Juhee Cho, Danbee Kang, Hye Yun Park
BACKGROUND: The association between longitudinal body mass index (BMI) change and clinical outcomes in patients with chronic obstructive pulmonary disease (COPD) has not fully investigated. METHODS: This retrospective cohort study included 116,463 COPD patients aged ≥ 40, with at least two health examinations, one within 2 years before and another within 3 years after COPD diagnosis (January 1, 2014, to December 31, 2019). Associations between BMI percentage change with all-cause mortality, primary endpoint, and initial severe exacerbation were assessed...
March 30, 2024: Respiratory Research
https://read.qxmd.com/read/38555458/astaxanthin-attenuates-cigarette-smoke-induced-small-airway-remodeling-via-the-akt1-signaling-pathway
#14
JOURNAL ARTICLE
Haidong Ding, Liming Yan, Yu Wang, Ye Lu, Mingming Deng, Yingxi Wang, Qiuyue Wang, Xiaoming Zhou
BACKGROUND: Astaxanthin (AXT) is a keto-carotenoid with a variety of biological functions, including antioxidant and antifibrotic effects. Small airway remodeling is the main pathology of chronic obstructive pulmonary disease (COPD) and is caused by epithelial-to-mesenchymal transition (EMT) and fibroblast differentiation and proliferation. Effective therapies are still lacking. This study aimed to investigate the role of AXT in small airway remodeling in COPD and its underlying mechanisms...
March 30, 2024: Respiratory Research
https://read.qxmd.com/read/38555433/clinical-characterization-and-outcomes-of-impulse-oscillometry-defined-bronchodilator-response-an-ecopd-cohort-based-study
#15
JOURNAL ARTICLE
Lifei Lu, Fan Wu, Jieqi Peng, Xiaohui Wu, Xiangqing Hou, Youlan Zheng, Huajing Yang, Zhishan Deng, Cuiqiong Dai, Ningning Zhao, Kunning Zhou, Qi Wan, Gaoying Tang, Jiangyu Cui, Shuqing Yu, Xiangwen Luo, Changli Yang, Shengtang Chen, Pixin Ran, Yumin Zhou
BACKGROUND: The clinical significance of the impulse oscillometry-defined small airway bronchodilator response (IOS-BDR) is not well-known. Accordingly, this study investigated the clinical characteristics of IOS-BDR and explored the association between lung function decline, acute respiratory exacerbations, and IOS-BDR. METHODS: Participants were recruited from an Early Chronic Obstructive Pulmonary Disease (ECOPD) cohort subset and were followed up for two years with visits at baseline, 12 months, and 24 months...
March 30, 2024: Respiratory Research
https://read.qxmd.com/read/38555425/novel-insights-and-new-therapeutic-potentials-for-macrophages-in-pulmonary-hypertension
#16
REVIEW
Yifan Zuo, Boyang Li, Minglang Gao, Rui Xiong, Ruyuan He, Ning Li, Qing Geng
Inflammation and immune processes underlie pulmonary hypertension progression. Two main different activated phenotypes of macrophages, classically activated M1 macrophages and alternatively activated M2 macrophages, are both involved in inflammatory processes related to pulmonary hypertension. Recent advances suggest that macrophages coordinate interactions among different proinflammatory and anti-inflammatory mediators, and other cellular components such as smooth muscle cells and fibroblasts. In this review, we summarize the current literature on the role of macrophages in the pathogenesis of pulmonary hypertension, including the origin of pulmonary macrophages and their response to triggers of pulmonary hypertension...
March 30, 2024: Respiratory Research
https://read.qxmd.com/read/38553757/association-between-the-rox-index-and-mortality-in-patients-with-acute-hypoxemic-respiratory-failure-a-retrospective-cohort-study
#17
JOURNAL ARTICLE
Kai Liu, Xin-Yi Ma, Hua Xiao, Wan-Jie Gu, Jun Lyu, Hai-Yan Yin
BACKGROUND: Although ROX index is frequently used to assess the efficacy of high-flow nasal cannula treatment in acute hypoxemic respiratory failure (AHRF) patients, the relationship between the ROX index and the mortality remains unclear. Therefore, a retrospective cohort study was conducted to evaluate the ability of the ROX index to predict mortality risk in patients with AHRF. METHOD: Patients diagnosed with AHRF were extracted from the MIMIC-IV database and divided into four groups based on the ROX index quartiles...
March 29, 2024: Respiratory Research
https://read.qxmd.com/read/38553722/patients-evaluation-of-aftercare-following-hospitalization-for-covid-19-satisfaction-and-unmet-needs
#18
JOURNAL ARTICLE
Julia C Berentschot, Willemijn A de Ridder, L Martine Bek, Majanka H Heijenbrok-Kal, Gert-Jan Braunstahl, Sylvia C Remerie, Yvonne Stuip, Gerard M Ribbers, Joachim G J V Aerts, Erwin Ista, Merel E Hellemons, Rita J G van den Berg-Emons
BACKGROUND: Patient experiences with COVID-19 aftercare remain largely unknown. We evaluated COVID-19 aftercare from a patient perspective one year after hospitalization, assessing satisfaction and its associated factors, and unmet needs. METHODS: The Satisfaction with COVID-19 Aftercare Questionnaire (SCAQ) was developed as part of a multicenter prospective cohort study and administered one year after hospital discharge. The SCAQ assesses (1) patient satisfaction, comprising information provision, rehabilitation, follow-up by hospitals and general practitioners (GPs), the most important aftercare topics, and overall satisfaction, and (2) unmet needs...
March 29, 2024: Respiratory Research
https://read.qxmd.com/read/38553718/development-of-a-nomogram-based-on-the-clinicopathological-and-ct-features-to-predict-the-survival-of-primary-pulmonary-lymphoepithelial-carcinoma-patients
#19
JOURNAL ARTICLE
Kai Nie, Lin Zhu, Yuxuan Zhang, Yinan Chen, John Parrington, Hong Yu
BACKGROUND: The aim of this study was to develop a nomogram by combining chest computed tomography (CT) images and clinicopathological predictors to assess the survival outcomes of patients with primary pulmonary lymphoepithelial carcinoma (PLEC). METHODS: 113 patients with stage I-IV primary PLEC who underwent treatment were retrospectively reviewed. The Cox regression analysis was performed to determine the independent prognostic factors associated with patient's disease-free survival (DFS) and cancer-specific survival (CSS)...
March 29, 2024: Respiratory Research
https://read.qxmd.com/read/38528530/early-smoking-lead-to-worse-prognosis-of-copd-patients-a-real-world-study
#20
JOURNAL ARTICLE
Jiankang Wu, Weiwei Meng, Yiming Ma, Zhiqi Zhao, Ruoyan Xiong, Jiayu Wang, Rui Zhao, Huihui Zeng, Yan Chen
BACKGROUND: Smoking remains a major risk factor for the development and progression of chronic obstructive pulmonary disease (COPD). Due to the adolescent smoking associated with worse health state, the age, at which an individual started smoking, might play a key role in shaping the trajectory of COPD development and the severity. METHODS: We conducted an observational study from September 2016 through January 2023 of eligible patients hospitalized with COPD. Patients who started smoking during the alveolar development stage (ADS, smoking initiation ≤ 24 years old) were defined as early smoking patients, and patients who started smoking after ADS (smoking initiation > 24 years old) were defined as late smoking patients...
March 25, 2024: Respiratory Research
journal
journal
39252
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.